Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.7K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

10.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.8K
Coagulation01:09

Coagulation

8.3K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.3K
Coagulation01:06

Coagulation

1.5K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.5K
Introduction to Hemostasis01:05

Introduction to Hemostasis

13.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preoperative daily step count and cognitive performance following cardiac surgery.

JTCVS open·2026
Same author

White paper: robotic cholecystectomy-new technology but safe principles still apply.

Surgical endoscopy·2026
Same author

Initial Clinical Experience With Partial Heart Transplantation for Mitral Valve Replacement: An Experimental Approach.

The Annals of thoracic surgery·2026
Same author

Rethinking Neonatal Surgical Urgency: Effective Delay with Internal Flow Restrictors.

The Annals of thoracic surgery·2026
Same author

Partial Heart Transplantation: A Review for Critical Care and Advanced Practice Nurses.

AACN advanced critical care·2026
Same author

Adolescents' perceptions of media messages and their preventive health behaviors: a longitudinal study.

Pediatric research·2026

Related Experiment Video

Updated: Apr 26, 2026

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

16.3K

How hemostatic agents interact with the coagulation cascade.

Douglas M Overbey, Edward L Jones, Thomas N Robinson

    AORN Journal
    |August 1, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Achieving surgical hemostasis involves direct pressure and vessel repair. Topical hemostatic agents are crucial when these methods fail, augmenting clot formation by interacting with the coagulation cascade.

    Keywords:
    clotting cascadecoagulationhemodynamic stabilityhemostasishemostatic agents

    More Related Videos

    The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
    06:59

    The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

    Published on: February 27, 2026

    165
    Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
    09:41

    Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

    Published on: March 5, 2020

    9.1K

    Related Experiment Videos

    Last Updated: Apr 26, 2026

    A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
    09:38

    A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

    Published on: February 14, 2017

    16.3K
    The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
    06:59

    The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

    Published on: February 27, 2026

    165
    Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
    09:41

    Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

    Published on: March 5, 2020

    9.1K

    Area of Science:

    • Surgical hemostasis
    • Coagulation cascade
    • Topical hemostatic agents

    Background:

    • Hemostasis is vital for maintaining hemodynamic stability and surgical visibility.
    • Initial hemostasis relies on direct pressure to activate the coagulation cascade.
    • Standard surgical techniques include vessel repair, ligation, and thermal coagulation.

    Purpose of the Study:

    • To review the role of topical hemostatic agents in surgery.
    • To explain the interaction of hemostatic agents with the coagulation cascade.
    • To emphasize the importance of understanding these interactions for optimal outcomes.

    Main Methods:

    • Review of established surgical hemostasis techniques.
    • Analysis of the application and mechanisms of topical hemostatic agents.
    • Discussion of the coagulation cascade's role in clot formation.

    Main Results:

    • First-line hemostasis methods include direct pressure, sutures, clips, staples, and thermal devices.
    • Topical hemostatic agents are employed when initial methods are insufficient.
    • These agents enhance clot formation by interacting with the coagulation system.

    Conclusions:

    • Effective surgical hemostasis requires a comprehensive approach.
    • Topical hemostatic agents provide an essential adjunct to traditional methods.
    • Understanding the mechanism of action of hemostatic agents is key to successful surgical outcomes.